APA (7th ed.) Citation

Schöffski, P., Ray-Coquard, I. L., Cioffi, A., Bui, N. B., Bauer, S., Hartmann, J. T., . . . Hohenberger, P. (2011). Activity of eribulin mesylate in patients with soft-tissue sarcoma: A phase 2 study in four independent histological subtypes. The lancet. Oncology, 12(11), . https://doi.org/10.1016/S1470-2045(11)70230-3

Chicago Style (17th ed.) Citation

Schöffski, Patrick, et al. "Activity of Eribulin Mesylate in Patients with Soft-tissue Sarcoma: A Phase 2 Study in Four Independent Histological Subtypes." The Lancet. Oncology 12, no. 11 (2011). https://doi.org/10.1016/S1470-2045(11)70230-3.

MLA (9th ed.) Citation

Schöffski, Patrick, et al. "Activity of Eribulin Mesylate in Patients with Soft-tissue Sarcoma: A Phase 2 Study in Four Independent Histological Subtypes." The Lancet. Oncology, vol. 12, no. 11, 2011, https://doi.org/10.1016/S1470-2045(11)70230-3.